Scholars Central

Research articlePublished 2015

Clinical Factors Relating to Cervical Body Volume Reduction during Curative External Beam Radiation Therapy for Head and Neck Cancer

Authors: Ken Takeda, Suguru Dobashi, Shinya Komori, Koichi Chida, Noriyuki Kadoya, Satoshi Kida, Kengo Ito, Toshiyuki Sugawara, Masaki Kubozono, Rei Umezawa, Yojiro Ishikawa, Takaya Yamamoto, Maiko Kozumi, Noriyoshi Takahashi, Yu Katagiri, Yusuke Onozato, Takayuki Kanai, Kiyokazu Sato, Kazuma Kishi, Haruo Matsushita, Takenori Ogawa, Yukio Katori, Keiichi Jin

Nuclear Medicine & Radiation Therapy

Volume 6 · Issue 1 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Purpose/Objectives: Substantial cervical body volume reduction (CBVR) occurs during fractionated external beam radiation therapy (EBRT) for head-and-neck cancer (HNC) and could have potential dosimetric influences. This study aims to investigate measurable clinical factors before treatment initiation correlating with CBVR during curative EBRT in HNC patients, and to determine which patients receive the great benefit from routine adaptive radiation therapy (ART). Materials/Methods: Fifty-six patients with oropharyngeal squamous cell carcinoma (OSCC) and 67 patients with hypopharyngeal squamous cell carcinoma (HSCC) had received curative EBRT between 2006 and 2013 were enrolled. For EBRT planning, computed tomography (CT) images were acquired before EBRT initiation and between two to seven weeks after the start of EBRT for replanning in each patient. A MATLAB program was used to evaluate the CBVR rate (CBVRR) between the initial and replanning CT imaging. The following factors were assessed for correlation with CBVRR: the T and N stage, induction and concurrent chemotherapy, the initial gross tumor volume (GTV), the GTV reduction rate (GTVRR) between the initial and replanning CT imaging, the initial body weight (BW) and the BW loss rate (BWLR) during the EBRT course. Results: In the OSCC group, the CBVRR ranged from 1.8 to 17.1% (median, 6.8%). In the HSCC group, the CBVRR ranged from 1.2 to 23.7% (median, 6.5%). In non-parametric univariate analysis, the N3 stage demonstrated a greater trend with the CBVRR than the N2c≥ stage in the HSCC group (p=0.023), whereas marginal inclination (p=0.096) was found in the OSCC group. The CBVRR was substantially related to the GTVRR (p=0.001) in the HSCC group.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Nuclear Medicine & Radiation Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalNuclear Medicine & Radiation Therapy
  • SubjectRadiology & Imaging
  • SubjectEnergy & Power
  • BylineArticles whose byline prints “Ken Takeda”
  • BylineArticles whose byline prints “Suguru Dobashi”
  • BylineArticles whose byline prints “Shinya Komori”
  • BylineArticles whose byline prints “Koichi Chida”
  • BylineArticles whose byline prints “Noriyuki Kadoya”
  • BylineArticles whose byline prints “Satoshi Kida”
  • BylineArticles whose byline prints “Kengo Ito”
  • BylineArticles whose byline prints “Toshiyuki Sugawara”